Particle.news
Download on the App Store

PACS Group Soars on Q3 Beat, Restatement Completion, 2025 Guidance

A completed restatement with current SEC filings eased governance concerns.

Overview

  • Shares jumped about 45% after hours and climbed more than 55% Thursday, reaching a 52-week high.
  • Third-quarter revenue came in around $1.34–$1.35 billion with net income of about $52 million and adjusted EBITDA of $131.5 million.
  • Sales topped consensus near $976 million while EPS of 32 cents trailed the 33-cent expectation by a penny.
  • The Audit Committee finished its probe as the company restated Q1 and Q2 2024 results, reducing revenue by $14.9 million and $46.1 million, and brought SEC filings current through Q3 2025.
  • Management guided 2025 revenue to $5.25–$5.35 billion and adjusted EBITDA to $480–$490 million, citing strong portfolio quality, 94.8% mature occupancy, and $355.7 million in cash.